IRCCS San Raffaele Pisana, 00166 Rome, Italy.
Roessingh Research and Development, 7522 AH Enschede, The Netherlands.
Int J Environ Res Public Health. 2020 Oct 28;17(21):7893. doi: 10.3390/ijerph17217893.
Pervasive health technologies can increase the effectiveness of personal health monitoring and training, but more user studies are necessary to understand the interest for these technologies, and how they should be designed and implemented. In the present study, we evaluated eWALL, a user-centered pervasive health technology consisting of a platform that monitors users' physical and cognitive behavior, providing feedback and motivation via an easy-to-use, touch-based user interface. The eWALL was placed for one month in the home of 48 subjects with a chronic condition (chronic obstructive pulmonary disease-COPD or mild cognitive impairment-MCI) or with an age-related impairment. User acceptance, platform use, and potential clinical effects were evaluated using surveys, data logs, and clinical scales. Although some features of the platform need to be improved before reaching technical maturity and making a difference in patients' lives, the real-life evaluation of eWALL has shown how some features may influence patients' intention to use this promising technology. Furthermore, this study made it clear how the free use of different health apps is modulated by the real needs of the patient and by their usefulness in the context of the patient's clinical status.
普及性健康技术可以提高个人健康监测和培训的效果，但需要更多的用户研究来了解这些技术的兴趣，以及应该如何设计和实施这些技术。在本研究中，我们评估了 eWALL，这是一种以用户为中心的普及性健康技术，由一个监测用户身体和认知行为的平台组成，通过易于使用的基于触摸的用户界面提供反馈和激励。eWALL 在 48 名患有慢性疾病（慢性阻塞性肺疾病或轻度认知障碍）或与年龄相关的障碍的受试者家中放置了一个月。使用调查、数据日志和临床量表评估用户接受度、平台使用情况和潜在的临床效果。尽管该平台的一些功能在达到技术成熟度并对患者生活产生影响之前需要改进，但 eWALL 的实际评估表明了一些功能如何影响患者使用这项有前途的技术的意愿。此外，本研究还清楚地表明，不同健康应用程序的免费使用是如何受到患者实际需求以及它们在患者临床状况背景下的有用性的调节的。
